Indivior Pharmaceuticals, Inc. ·
INDV 8-K 2026-09-17
Indivior Pharmaceuticals, Inc. (INDV) 8-K dated 2026-09-17 — accession 0001104659-26-108417.
Indivior Pharmaceuticals, Inc. (INDV) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Indivior Pharmaceuticals, Inc. filed a 8-K on 2026-09-17. Accession 0001104659-26-108417.
This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported INDV revenue for 2025-12-31 was $1.24B. Net income was $210.0M. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. INDV currently screens at market cap $4.48B.
Not investment advice. The INDV SEC hub lists recent forms. The stock page is the research view.